1 in 4 adults consider weight loss drug use without prescription: Study
New Delhi, Sep 17 (IANS) Even as injectable weight loss drugs have become a popular option for people struggling with obesity, 1 in 4 or 25 per cent consider using them without consulting their doctor, exposing themselves to several health risks, finds a study on Tuesday. Cost and lack of insurance coverage are some reasons
New Delhi, Sep 17 (IANS) Even as injectable weight loss drugs have become a popular option for people struggling with obesity, 1 in 4 or 25 per cent consider using them without consulting their doctor, exposing themselves to several health risks, finds a study on Tuesday.
Cost and lack of insurance coverage are some reasons for seeking prescription alternatives, said the team from The Ohio State University, US, who surveyed 1,006 adults in America.
“Some people are skipping the doctor’s office and reaching out to potentially unreliable sources such as unlicensed online pharmacies or telehealth sites, which could expose patients to risks,” the team said.
Cost (18 per cent) is the major reason identified in the survey, followed by not being covered by insurance (15 per cent), inability to get a prescription from their doctor (9 per cent), and lack of availability through a pharmacy (6 per cent).
“It’s really important for those who want to lose weight to first discuss options with their doctor. It is not one size fits all, and every medication can have risks and side effects,” said Shengyi Mao, an Ohio State internal medicine physician.
Mao said doctors will “go through a patient’s medical history” and prescribe medications by assessing “their particular risks and benefits”.
Recently developed weight loss drugs called GLP1-RA (with brand names Ozempic and Wegovy) help in weight loss because they can curb appetite and slow emptying of the stomach.
The medication which comes with Semaglutide salt has been approved by the US FDA for reducing cardiovascular risk in adults who are overweight or obese and have established cardiovascular disease.
But the regulator also issued two warnings about compounded Semaglutide including reports of dosing errors resulting in hospitalisation and ineffective ingredients.
Compounded drugs are custom-made alternatives to brand names and made in state-licensed pharmacies instead of by drug manufacturers when a drug is in short supply.
Mao said “Obesity is a serious and complex chronic disease” and should be addressed by a “comprehensive weight management programme”.
“These weight loss drugs may be effective for some people but they can cause serious side effects and the weight may return after they stop taking them.”
–IANS
rvt/
Know all about new XEC Covid variant identified in 15 countries
Next Articleଶ୍ରୀମନ୍ଦିରରେ ଶ୍ରୀଜୀଉଙ୍କ ବଳିବାମନ ବେଶ ଅନୁଷ୍ଠାନ
Related Articles
New AI tool to revolutionise personalised cancer treatment

ସ୍ୱାସ୍ଥ୍ୟ ଓ ଜୀବନଶୈଳୀNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Covid-19 virus protein triggers immune attack on healthy cells: Study

ସ୍ୱାସ୍ଥ୍ୟ ଓ ଜୀବନଶୈଳୀCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
Global AI collaboration revolutionises personalised cancer treatment

ସ୍ୱାସ୍ଥ୍ୟ ଓ ଜୀବନଶୈଳୀGlobal AI collaboration revolutionises personalised cancer treatment
New Delhi: An international team of scientists has unveiled an artificial intelligence (AI) technique that securely analyses global cancer samples, paving the way for more personalised and privacy-protected cancer treatments. This innovative approach promises to accelerate personalised cancer treatment by enabling clinicians to match therapies to individual patients better, Xinhua news agency reported. The study
